| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.003 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.004 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.007 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.007 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.008 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.008 |